Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
JD Health International, Inc. ( (HK:6618) ) has issued an update.
JD Health International Inc. has launched a new on-market share repurchase programme authorizing buybacks of up to US$1.0 billion over a 48‑month period, subject to annual shareholder mandates and regulatory limits. The board says the move reflects confidence in the company’s long-term outlook and aims to enhance shareholder value while avoiding any mandatory takeover offer obligations.
The repurchases will be conducted in compliance with Hong Kong listing rules, Cayman Islands law and takeover and buy-back codes, including blackout restrictions around results announcements. Management stresses that buybacks will depend on market conditions and board discretion, with no assurance on the timing, volume or pricing of purchases, while maintaining that JD Health can fund the programme and preserve a solid financial position.
The most recent analyst rating on (HK:6618) stock is a Buy with a HK$71.00 price target. To see the full list of analyst forecasts on JD Health International, Inc. stock, see the HK:6618 Stock Forecast page.
More about JD Health International, Inc.
JD Health International Inc. is a Hong Kong-listed healthcare platform incorporated in the Cayman Islands, operating in the digital health and medical services industry. The company focuses on providing high-quality healthcare products and services, leveraging online channels to serve consumers and patients in mainland China and beyond.
Average Trading Volume: 7,752,265
Technical Sentiment Signal: Sell
Current Market Cap: HK$146.2B
See more data about 6618 stock on TipRanks’ Stock Analysis page.